Purchase Order HT940826PE007

The Defense Health Agency awarded a $27.7K purchase order to Werfen USA LLC on December 4, 2024, for equipment lease and support services related to the NEO IRIS Blood Analyzer System utilized by the Laboratory Transfusion Service at Lackland Air Force Base in Texas. This bridge action provides DHA additional time to conform their acquisition procedures while maintaining continuity of laboratory operations. The contract carries a firm fixed-price structure with no small business set-aside...

The Defense Health Agency awarded a purchase order to Werfen USA LLC valued at $483,044.80 for the lease of a blood bank analyzer and associated reagents with performance at Lawton, Oklahoma. The contract operates under a firm fixed-price structure with no small business set-aside and extends through September 30, 2030, with FY26 funds obligated at the time of award on October 1, 2025. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical...

The Defense Health Agency awarded a firm fixed-price purchase order to Werfen USA LLC for the lease of automated blood bank analyzers supporting the MACH Laboratory at Fort Moore, Georgia. The contract, valued at approximately $283,673, extends through September 30, 2027, with an award date of October 1, 2025. No small business set-aside was utilized for this procurement. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory...

This federal contract award, valued at $83,106.72, was issued by the Defense Health Agency to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The contract is for the lease of two blood chemistry analyzers to support the Wilford Hall Medical Center and Blood Donor Center at Joint Base San Antonio - Lackland, Texas. The equipment will be used to perform complex blood testing procedures,...

The Defense Health Agency issued a BPA call to Werfen USA LLC for $16,614.00 in consumables, with an award date of April 14, 2026 and ultimate completion date of April 14, 2026. Performance occurs at JBSA FT SAM Houston, Texas. The call was issued on a firm fixed-price basis with no set-aside. Werfen USA LLC manufactures and supplies in vitro diagnostic equipment, reagents, and laboratory consumables including coagulation analyzers, blood gas analyzers, hematology testing equipment, and blood...

The Defense Health Agency awarded a purchase order to Werfen USA LLC for reagents and warranty service, effective through September 30, 2027, with a ceiling value of $175,502.24 under firm fixed-price terms. The modification deobligates excess FY25 funds to reflect actual consumption during the period October 1, 2024 to September 30, 2025. Performance occurs at 2330 Stanley Road, Fort Sam Houston, Texas. The purchase order originated from a pre-solicitation opportunity posted July 14, 2022, with...

The Defense Health Agency awarded a $246,129.58 delivery order to Werfen USA LLC on October 1, 2025, for hematology analyzers with reagents to support clinical laboratory operations at William Beaumont Army Medical Center, Fort Bliss, Texas. This firm fixed-price contract, with an ultimate completion date of March 31, 2027, represents a FY26 funding modification under the Critical Analyzers, Laboratory GSA Schedule. No set-aside designation was used for this procurement, reflecting Werfen's...

The Defense Health Agency issued a delivery order to Sysmex America, Inc. on March 14, 2023, with a ceiling value of $2,276,928.81 under the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) for hematology equipment lease, supplies, and cost-per-test services on a firm fixed-price basis. Place of performance is Bethesda, MD. The order is scheduled for ultimate completion on March 15, 2028. The scope covers hematology analyzer equipment, reagents, supplies, and related...

The Defense Health Agency awarded a $64,637.68 firm fixed-price delivery order to Werfen USA LLC for two ACL Elite Pro Analyzers with associated consumables and reagents. The delivery order was executed on September 28, 2022, with an ultimate completion date of September 27, 2023, and is set to be performed at Twentynine Palms Marine Corps Base in California. This award was issued under the Critical Analyzers, Laboratory General Services Administration Schedule (FSS-66-III) and carries no...

The Defense Health Agency awarded a $271,134.68 firm fixed-price purchase order to Werfen USA LLC on December 30, 2021, for the procurement and delivery of an ACL TOP 350 coagulation instrument and coagulation testing services at the National Training Center located at Fort Irwin, California. The contract carries an ultimate completion date of December 29, 2026, and was executed without a set-aside designation, allowing full and open competition. Werfen USA LLC, a Bedford, Massachusetts-based...